Stigma and disaster risk reduction among vulnerable groups: Considering people receiving opioid substitution treatment-Reference-Cited by-同舟云学术

Stigma and disaster risk reduction among vulnerable groups: Considering people receiving opioid substitution treatment

Published:2020-09 Issue: Volume:48 Page:101588
ISSN:2212-4209
Container-title:International Journal of Disaster Risk Reduction
language:en
Short-container-title:International Journal of Disaster Risk Reduction

Author:

Blake Denise,Pooley Sheridan,Lyons Antonia

Funder

Massey University Research

Publisher

Elsevier BV

Subject

Geology,Safety Research,Geotechnical Engineering and Engineering Geology

Reference62 articles.

1. New Zealand Practice Guidelines for Opioid Substitution Treatment;Ministry of Health,2014

2. New Zealand Clinical Guidelines for the Use of Buprenorphine (With or without Naloxone) in the Treatment of Opioid Dependence;Ministry of health,2014

3. Substance-related and Addictive Disorders;American Psychiatric Association,2015

4. The clinical opiate withdrawal scale (COWS);Wesson;J. Psychoact. Drugs,2003

5. Challenges to Opioid Treatment Programs after Hurricane Sandy: Patient and Provider Perspectives on Preparation, Impact, and Recovery;Matusow,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Closing a Street Sex Work Zone Impacts Sex Workers’ Vulnerability: A Longitudinal Qualitative Study on a Tippelzone in the Netherlands;Sexuality Research and Social Policy;2024-08-02

2. Losing everything: Experiences of a flood for people who inject drugs in Aotearoa New Zealand;International Journal of Disaster Risk Reduction;2024-05

4. Medication safety, privacy, and stigma: A qualitative study of pharmacy opioid agonist treatment disruptions and adaptations in the 2022 Northern Rivers floods, Australia;International Journal of Disaster Risk Reduction;2024-02

5. The Patient Perspective of an Inpatient Addiction Medicine Unit Implemented in an Urban Northern Acute Care Hospital in Ontario, Canada;Substance Use: Research and Treatment;2024-01